Guy N
Well-Known Member
Even though the FDA has recommended that a certain drug no longer be sold as a breast cancer treatment, Medicare will continue to pay for the drug. The drug in question costs about $88,000 per year per patient.
Stories like this helps you understand why Medicare is in trouble. If a drug isn't beneficial for cancer treatment, why would Medicare pay $88,000 per year for a patient to be prescribed this medicine?
Read More
Stories like this helps you understand why Medicare is in trouble. If a drug isn't beneficial for cancer treatment, why would Medicare pay $88,000 per year for a patient to be prescribed this medicine?
Read More